This content is from: United States Incoming health secretary unnerves pharma in-house counsel Senior in-house sources in innovator and generic drug companies reveal to Managing IP that they’re concerned about Xavier Becerra’s pharma antitrust record By Patrick Wingrove January 25 2021
This content is from: United States Plaintiffs consider bench trials to combat litigation backlog By Rani Mehta January 22 2021
This content is from: European Union CJEU cheese ruling boosts food makers’ GI enforcement By Max Walters January 22 2021
This content is from: International This week in IP: WSOU most litigious NPE, UK appoints new IP judge, Trump appointees re... By Patrick Wingrove January 22 2021
This content is from: United States In-house: new university patent pool will ease licensing efforts By Rani Mehta January 21 2021
This content is from: International Anti-anti-suit injunctions create ‘risky’ FRAND playing fields By Charlotte Kilpatrick January 21 2021
This content is from: International Monoclonal antibody biosimilars pose unique IP challenges By Charlotte Kilpatrick January 21 2021
This content is from: India ASCI move in to clamp misleading COVID-19 claims in India By Daleep Kumar & Ranjan Narula January 25 2021
This content is from: South Korea Drug patent expiry in 2021: Opportunities and challenges in the Korean market By Min Son January 12 2021
This content is from: Local Insights Restricting the scope of claims by introducing disclaimers in Taiwan By Chiu-Ling Lin January 12 2021
This content is from: Germany German court rules against automated dispensing of medicinal products By Christian Meyer January 07 2021
.svg)
